March 20, 2024
by Natalia Honchar
Biopharma insight
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences …
April 23, 2024
by Andrii Buvailo, PhD
News
As first reported by Endpoints News, Xaira Therapeutics has emerged as one of the most significantly funded new entrants in …
June 23, 2023
by Bohdana Sokolova
Biopharma insight
Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and …
June 28, 2023
by Dana Sokolova
Biopharma insight
The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting …
Jan. 5, 2024
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
June 29, 2023
by Irina Bilous
Biopharma insight
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications …
March 5, 2024
by Andrii Buvailo, PhD
News
Elsevier, a global provider of information and analytics in science and health with 140 years of history, has entered into …
Feb. 28, 2024
by Andrii Buvailo, PhD
News
It is a remarkable day for Ginkgo Bioworks, a notable player in the field of synthetic biology, as the company …
Jan. 23, 2024
by Andrii Buvailo
Interview
The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …
Feb. 13, 2024
by Dana Sokolova
Biopharma insight
The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement. The biopharma field is …
March 11, 2024
by Andrii Buvailo, PhD
News
Recursion (NASDAQ: RXRX), a clinical-stage TechBio company, has unveiled plans to establish a new office in London's King’s Cross area, …
March 25, 2024
by Andrii Buvailo, PhD
Biopharma insight
The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021. …